Valuation: Cipla Limited

Capitalization 1,191B 13.72B 13.09B 12.36B 10.87B 19.46B 21.6B 147B 54.39B 497B 51.42B 50.4B 2,079B P/E ratio 2025 *
23.9x
P/E ratio 2026 * 22.9x
Enterprise value 1,109B 12.78B 12.19B 11.52B 10.13B 18.13B 20.12B 137B 50.66B 463B 47.9B 46.95B 1,936B EV / Sales 2025 *
4.03x
EV / Sales 2026 * 3.6x
Free-Float
63.97%
Yield 2025 *
0.77%
Yield 2026 * 0.81%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.04%
1 week+0.16%
Current month-0.32%
1 month+1.86%
3 months-1.67%
6 months-5.70%
Current year-3.55%
More quotes
1 week
1 431.55
Extreme 1431.55
1 493.00
1 month
1 366.10
Extreme 1366.1
1 493.00
Current year
1 366.10
Extreme 1366.1
1 543.45
1 year
1 317.25
Extreme 1317.25
1 702.05
3 years
852.00
Extreme 852
1 702.05
5 years
355.30
Extreme 355.3
1 702.05
10 years
355.30
Extreme 355.3
1 702.05
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 2016-08-31
Director of Finance/CFO - 2022-08-15
President - 2019-12-31
Director TitleAgeSince
Chairman 88 1972-07-20
Director/Board Member 71 2014-07-24
Director/Board Member 53 2016-08-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+1.04%+0.16%+3.46%+54.43% 13.61B
+0.81%-2.03%+12.75%+98.21% 47.1B
+3.75%-4.11%+39.86%+91.73% 25.87B
-3.66%-2.56%+50.93% - 21.78B
+2.44%-7.07%+6.46%+141.45% 10.48B
-.--%+0.14% - - 6.79B
-.--%-1.95% - - 5.73B
-0.30%-0.91%+38.56%+44.05% 5.3B
-0.37%+2.49%+11.45%+35.66% 5.12B
-0.46%-1.53%-39.12%-47.06% 4.7B
Average +0.32%-2.00%+15.54%+59.78% 14.65B
Weighted average by Cap. +0.61%-2.85%+21.91%+83.95%
See all sector performances

Financials

2025 *2026 *
Net sales 276B 3.17B 3.03B 2.86B 2.52B 4.5B 5B 33.96B 12.58B 115B 11.9B 11.66B 481B 300B 3.45B 3.29B 3.11B 2.74B 4.9B 5.44B 36.94B 13.69B 125B 12.94B 12.68B 523B
Net income 49.97B 576M 549M 519M 456M 817M 906M 6.16B 2.28B 20.86B 2.16B 2.11B 87.23B 52.17B 601M 573M 542M 476M 852M 946M 6.43B 2.38B 21.78B 2.25B 2.21B 91.07B
Net Debt -81.61B -940M -897M -847M -745M -1.33B -1.48B -10.06B -3.73B -34.07B -3.52B -3.45B -142B -113B -1.3B -1.24B -1.17B -1.03B -1.84B -2.05B -13.9B -5.15B -47.08B -4.87B -4.77B -197B
More financial data * Estimated data
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
27,764
More about the company
Date Price Change Volume
25-02-17 1,474.65 +1.04% 1,113,888
25-02-14 1,459.45 -0.86% 1,703,559
25-02-13 1,472.15 +1.58% 1,879,916
25-02-12 1,449.20 -0.27% 1,791,670
25-02-11 1,453.15 -0.39% 1,938,792

Delayed Quote NSE India S.E., February 17, 2025 at 06:49 am EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,474.65INR
Average target price
1,644.19INR
Spread / Average Target
+11.50%
Consensus

Quarterly revenue - Rate of surprise